Molecular characterization of a full-length genome of a HIV-2 isolate from India

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):329-35. doi: 10.1097/QAI.0b013e3181b766be.

Abstract

Background: India accounts for 95% of HIV-2 infections in Asia. Molecular epidemiological studies have been performed on HIV-2 partial envelope gene and LTR sequences from isolates in India. Although, a single full-length sequence of an isolate from India is available in the GenBank, a comprehensive molecular analysis of a large number of HIV-2 isolates would be essential for understanding the genomic heterogeneity of HIV-2 isolates prevalent in the country.

Methods: In this study, we determined the complete nucleotide and deduced amino acid sequence of a HIV-2 isolate that was obtained by coculture of infected cells. An extensive full-length genome analysis was performed with sequences available from the GenBank.

Results: The isolate belonged to HIV-2 subtype A. Comparison of the genomic sequence with those of the 18 full-length sequences obtained from the GenBank showed the genetic distance ranging from 7.8% with CRIK (subtype A, India) to 30% with EHO (subtype B, Cote d'ivoire).

Conclusions: Phylogenetic analysis indicated that this isolate exhibited close homology with CRIK. Analysis of the gene sequences indicated presence of 2 mutations associated with drug resistance to nucleoside reverse transcriptase inhibitors. Mutations associated with protease inhibitors were not observed in the isolate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amino Acid Sequence
  • Anti-HIV Agents / pharmacology
  • Base Sequence
  • Drug Resistance, Viral / genetics
  • Gene Expression Regulation, Viral / physiology
  • Genome, Viral*
  • HIV Infections / epidemiology
  • HIV Infections / virology
  • HIV-2 / drug effects
  • HIV-2 / genetics*
  • HIV-2 / metabolism*
  • Humans
  • India / epidemiology
  • Male
  • Molecular Sequence Data
  • Phylogeny

Substances

  • Anti-HIV Agents